HMS Valuation Partners
HMS Valuation Partners states that it is exclusively focused on healthcare and provides valuation and transaction advisory services, including support for mergers and acquisitions, physician compensation arrangements, and other healthcare transactions.
HMS Valuation Partners is a healthcare-focused valuation and transaction advisory firm.
Its public materials describe valuation work, transaction support, and healthcare regulatory analysis rather than a buyer or investment-platform model.[1][2][3][5][6][8]
What does HMS Valuation Partners do?
HMS Valuation Partners is the operating name presented on hmsvalue.com. The firm states that it is exclusively focused on healthcare and provides healthcare valuation and transaction advisory services, including support for mergers and acquisitions and other healthcare transactions.[1][2] Publicly stated services include healthcare business valuation, transaction advisory support, physician compensation arrangements, timeshare leases, professional services agreements, and other healthcare transactions. HMS also describes valuation work supporting physician practice arrangements and ambulatory surgery center acquisitions.[2][5]Owners comparing advisory firms can also review Auxo’s M&A advisor vs. business broker vs. investment bank comparison, advisor-selection guide, and sell-side advisor evaluation framework.
What should a business owner evaluate before hiring HMS Valuation Partners?
An owner evaluating HMS should clarify the scope of transaction support beyond valuation analysis, including whether the engagement covers sell-side process management, buyer outreach, or negotiation support. The owner should also confirm the applicable fee structure and engagement terms, the relevant healthcare transaction experience, and the deliverables for fair-market-value, commercial-reasonableness, Stark Law, and Anti-Kickback requirements.[2][8]Does HMS provide sell-side M&A advisory services, or is its role limited to valuation and transaction-support work
How are fees structured, including fixed fees, hourly fees, success fees, minimums, termination provisions, and tail periods
What size transactions and clients does HMS Valuation Partners focus on?
HMS states that it is exclusively focused on the healthcare industry. Its identified client types include single hospitals, regional and multinational health systems, large and small physician groups, healthcare law firms, management consulting firms, and private equity firms.[1][2] The official Valuation Views index displays content categories including case studies and news, but the displayed index does not identify completed transactions by client, buyer, seller, date, or transaction value.[6] HMS publicly describes support for mergers and acquisitions, physician practice arrangements, ambulatory surgery center acquisitions, and other healthcare transactions. Its business valuation work analyzes financial, production, and operational information in support of physician practice arrangements and ASC acquisitions.[2][5]What does HMS Valuation Partners publicly disclose about fees, process and engagement terms?
The official Valuation Views index does not identify completed transactions by client, buyer, seller, date, or transaction value. The official healthcare valuation services page does not publish a standard fee schedule, minimum fee, success-fee percentage, termination provision, or tail period.[2][6] A USPTO Office Action identifies Health Management Solutions, L.L.C. as the applicant for the HMS VALUATION PARTNERS trademark application. HMS also publicly describes fair-market-value and commercial-reasonableness work addressing healthcare regulatory considerations, including Stark Law and Anti-Kickback requirements. The official physician compensation valuation page does not state that HMS is a broker-dealer, investment adviser, or other securities registrant, and it does not provide a firm-level securities-registration identifier.[7][8] HMS publicly describes a systematic and process-driven approach to valuation engagements, including analysis of financial, production, and operational information.[5]Questions to ask before hiring HMS Valuation Partners
Does HMS provide sell-side M&A advisory services, or is its role limited to valuation and transaction-support work?
Which transaction services are included beyond the valuation opinion?
How are fees structured, including fixed fees, hourly fees, success fees, minimums, termination provisions, and tail periods?
What healthcare subsectors and transaction sizes are most common in current engagements?
Can HMS provide anonymized examples of recent physician-practice, ASC, hospital, or other healthcare transactions?
Which team members would lead the engagement, and what conflicts checks and independence procedures apply?
What deliverables are provided for Stark Law, Anti-Kickback, commercial-reasonableness, or other compliance needs?
Sources & research notes
- Official website / firm overview
- Services / capabilities
- Geography / market coverage
- Geography / market coverage
- Investment approach
- Public disclosure information
- Structure / regulatory context
- Structure / regulatory context
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.